LYMPHANGIOMA

Clinical trials for LYMPHANGIOMA explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOMA trials appear

Sign up with your email to follow new studies for LYMPHANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare blood vessel disorders: everolimus trial launches

Disease control Not yet recruiting

This phase 2 trial tests the drug everolimus in 67 people with vascular anomalies (abnormal blood vessels) that haven't responded to standard treatments. The goal is to shrink the lesions and improve symptoms. Participants take everolimus daily for 6 months, with doses adjusted b…

Matched conditions: LYMPHANGIOMA

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

LYMPHANGIOMA

Get alerted when new LYMPHANGIOMA trials appear

New hope for rare blood vessel disorders: everolimus trial launches